8-60822634-A-G
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PP3PP5_Very_Strong
The NM_017780.4(CHD7):c.3089A>G(p.Asn1030Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_017780.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD7 | ENST00000423902.7 | c.3089A>G | p.Asn1030Ser | missense_variant | Exon 12 of 38 | 5 | NM_017780.4 | ENSP00000392028.1 | ||
CHD7 | ENST00000524602.5 | c.1717-39595A>G | intron_variant | Intron 2 of 4 | 1 | ENSP00000437061.1 | ||||
CHD7 | ENST00000525508.1 | c.3089A>G | p.Asn1030Ser | missense_variant | Exon 11 of 12 | 5 | ENSP00000436027.1 | |||
CHD7 | ENST00000695853.1 | n.3089A>G | non_coding_transcript_exon_variant | Exon 12 of 37 | ENSP00000512218.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 35982159, 33057194, 33879512, 21041284, 34171171, 25077900, 22539353) -
- -
CHARGE syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CHD7 protein function. This variant has been observed in individual(s) with CHARGE syndrome (PMID: 21041284) and in individual(s) with clinical features of Kallman syndrome (PMID: 25077900). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 279758). This variant is not present in population databases (ExAC no frequency). This sequence change replaces asparagine with serine at codon 1030 of the CHD7 protein (p.Asn1030Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at